Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism

Abstract Background The calcimimetic agent cinacalcet is effective for the management of secondary hyperparathyroidism (SHPT) in dialysis patients. Changes to reimbursement of cinacalcet in Australia provided an opportunity to assess effects of medication cessation on biochemical and clinical outcom...

Full description

Bibliographic Details
Main Authors: Irene Ruderman, Edward R. Smith, Nigel D. Toussaint, Tim D. Hewitson, Stephen G. Holt
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Nephrology
Subjects:
End-stage kidney disease
Secondary hyperparathyroidism
Dialysis
Calciprotein particles
Parathyroid hormone
Cinacalcet
Online Access:http://link.springer.com/article/10.1186/s12882-018-0910-9

Internet

http://link.springer.com/article/10.1186/s12882-018-0910-9

Similar Items